A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Ark Investment Management LLC holds 11,601,134 shares of ADPT stock, worth $74.1 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
11,601,134
Previous 11,412,000 1.66%
Holding current value
$74.1 Million
Previous $41.3 Million 43.78%
% of portfolio
0.56%
Previous 0.38%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$3.37 - $5.12 $637,381 - $968,366
189,134 Added 1.66%
11,601,134 $59.4 Million
Q2 2024

Jul 26, 2024

BUY
$2.34 - $3.96 $1.99 Million - $3.37 Million
850,704 Added 8.05%
11,412,000 $41.3 Million
Q1 2024

Apr 18, 2024

SELL
$2.88 - $4.8 $6.47 Million - $10.8 Million
-2,245,217 Reduced 17.53%
10,561,296 $33.9 Million
Q4 2023

Jan 17, 2024

BUY
$3.46 - $5.33 $4.49 Million - $6.91 Million
1,297,205 Added 11.27%
12,806,513 $62.8 Million
Q3 2023

Oct 18, 2023

BUY
$5.07 - $8.44 $5.35 Million - $8.91 Million
1,055,556 Added 10.1%
11,509,308 $62.7 Million
Q2 2023

Jul 10, 2023

BUY
$6.19 - $8.78 $7.73 Million - $11 Million
1,248,627 Added 13.56%
10,453,752 $70.1 Million
Q1 2023

Apr 17, 2023

BUY
$7.8 - $10.11 $30,264 - $39,226
3,880 Added 0.04%
9,205,125 $81.3 Million
Q4 2022

Jan 24, 2023

SELL
$6.26 - $9.34 $847,441 - $1.26 Million
-135,374 Reduced 1.45%
9,201,245 $0
Q3 2022

Oct 17, 2022

BUY
$6.5 - $12.67 $3.66 Million - $7.14 Million
563,601 Added 6.42%
9,336,619 $66.5 Million
Q2 2022

Jul 11, 2022

BUY
$6.4 - $14.73 $6.81 Million - $15.7 Million
1,063,352 Added 13.79%
8,773,018 $68.6 Million
Q1 2022

Apr 19, 2022

BUY
$10.12 - $28.9 $20.4 Million - $58.1 Million
2,011,798 Added 35.31%
7,709,666 $107 Million
Q4 2021

Jan 28, 2022

BUY
$25.17 - $36.85 $21.2 Million - $31 Million
841,447 Added 17.33%
5,697,868 $160 Million
Q3 2021

Nov 12, 2021

BUY
$30.02 - $39.87 $14.7 Million - $19.5 Million
489,444 Added 11.21%
4,856,421 $165 Million
Q2 2021

Aug 05, 2021

BUY
$32.22 - $44.59 $28.8 Million - $39.8 Million
893,067 Added 25.71%
4,366,977 $178 Million
Q1 2021

May 13, 2021

BUY
$37.26 - $67.74 $71.8 Million - $131 Million
1,928,207 Added 124.75%
3,473,910 $140 Million
Q4 2020

Feb 12, 2021

BUY
$45.01 - $65.47 $29.8 Million - $43.3 Million
660,981 Added 74.71%
1,545,703 $91.4 Million
Q3 2020

Oct 30, 2020

BUY
$35.79 - $48.81 $20.6 Million - $28.1 Million
575,584 Added 186.19%
884,722 $43 Million
Q2 2020

Aug 11, 2020

BUY
$24.95 - $48.38 $7.71 Million - $15 Million
309,138 New
309,138 $15 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $913M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.